June 23, 2026
Torrent Pharma Holds Its 53rd Annual General Meeting
Shareholders considered the FY2026 financial statements, dividends, a director reappointment and other resolutions.
#AGM #Governance
View postDevelop, manufacture and market pharmaceutical products for patients in India and international markets.
torrentpharma.comOperations started
1959Incorporated
July 15, 1972
Headquarters
Ahmedabad, Gujarat, India
Industry
Specialty and generic pharmaceuticals
Group
Torrent Group
Global presence
More than 50 countries
Manufacturing facilities
8
Listed on
NSE: TORNTPHARM and BSE: 500420
Revenue (FY2026)
₹13,980 croreProfit after tax (FY2026)
₹2,138 crore
Torrent Pharmaceuticals is the flagship company of Torrent Group. Its portfolio covers cardiovascular, central nervous system, gastrointestinal, women's healthcare, diabetes, pain management, oncology and anti-infective therapies.
The company began pharmaceutical operations in 1959 and was incorporated in 1972. It now reports eight manufacturing facilities and a commercial presence in more than 50 countries.
For fiscal 2026, Torrent Pharma reported ₹13,980 crore in revenue, ₹4,559 crore in operating EBITDA and ₹2,138 crore in profit after tax. The year included the first quarter of financial integration with JB Pharma.
Chairman
Managing Director
Non-Executive Director
Independent Director
Interview experience
Favourable
Interview difficulty
Medium
Interview process length
About two weeks
Practice pharmaceutical, quality, marketing and behavioral questions.
Q: Which marketing metrics have you used to evaluate a pharmaceutical brand?
A: Choose the metrics that match the brand objective, explain the data source and show how the findings changed a campaign or resource decision.
Q: Describe the marketing campaigns you have worked on.
A: Select one campaign, define the audience and objective, explain your contribution and close with measured commercial or engagement results.
Q: How do you assess a brand's size and growth opportunity?
A: Define the patient and prescriber segments, examine market and prescription data, assess competitors and state the assumptions behind your opportunity estimate.
Q: Briefly explain line clearance.
A: Describe the documented checks that remove prior materials, labels and records before a new batch or product begins, then explain why independent verification matters.
Practice pharmaceutical, quality, marketing and behavioral questions.
Employee-submitted annual pay
₹3 lakh to ₹6 lakh per year
53 Salaries submitted
Employee-submitted annual pay
₹6 lakh to ₹10 lakh per year
42 Salaries submitted
Employee-submitted annual pay
₹3 lakh to ₹5 lakh per year
28 Salaries submitted
Employee-submitted annual pay
₹3 lakh to ₹6 lakh per year
11 Salaries submitted
Employee-submitted annual pay
₹6 lakh to ₹20 lakh per year
8 Salaries submitted
Employee-submitted annual pay
₹3 lakh to ₹8 lakh per year
7 Salaries submitted
Compare employee-submitted annual-pay ranges for India roles.
Mumbai, Maharashtra, India • Full-time
Mumbai, Maharashtra, India • Full-time
Dahej, Gujarat, India • Not specified
Dahej, Gujarat, India • Not specified
Dahej, Gujarat, India • Not specified
Dahej, Gujarat, India • Not specified
Connect your pharmaceutical, marketing or engineering experience to the role.
June 23, 2026
Torrent Pharma Holds Its 53rd Annual General Meeting
Shareholders considered the FY2026 financial statements, dividends, a director reappointment and other resolutions.
#AGM #Governance
View postMay 22, 2026
Torrent Pharma Reports Q4 and FY2026 Results
The company reported FY2026 revenue of ₹13,980 crore and operating EBITDA of ₹4,559 crore.
#Results #Pharma
View postApril 10, 2026
Bileshwarpura Oncology Facility Inspection Ends With Zero Observations
Torrent said the USFDA inspection of its Bileshwarpura oncology facility concluded with zero observations.
#Quality #Manufacturing
View postFebruary 13, 2026
Torrent Pharma Reports Q3 FY2026 Results
Third-quarter revenue rose 18% year over year to ₹3,303 crore and profit after tax rose 26% to ₹635 crore.
#Earnings #Growth
View postJanuary 23, 2026
Dahej Facility Inspection Concludes
Torrent disclosed that the USFDA inspection of its Dahej manufacturing facility had concluded.
#USFDA #Dahej
View postIts official milestones page says pharmaceutical operations began in 1959.